How Will Demands For Effectiveness Evidence Change Drug Development

The project reported in this Occasional Paper was intended to determine how changing demands for evidence are affecting drug development in five global pharmaceutical companies: Amgen, Eli Lilly, GSK, Novartis and Sanofi-Aventis. Read more here. (Source: OHE, 4/23/14).

You might also be interested in:

For Shame: Congress Accuses Novartis, Amgen and Mallinckrodt… 10/02/2020
Trump's "Buy American" Executive Order Could Raise Drug Prices 08/06/2020
What Are The Recent Top 4 Innovative Consolidations and… 08/26/2020
Lilly + Prime Therapeutics Push the Envelope on Next… 08/12/2020
What Does $11M in Donations to Congress Buy Pharma? 08/12/2020
Stanford Center for Health Education Launches Online Program… 08/11/2020
Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020